GILEAD SCIENCES, INC. (GILD) insider buying and selling

NASDAQ: GILD · Source: SEC Form 4 filings · Latest trade reported

In the last 90 days at GILEAD SCIENCES, INC. (GILD), no insider made an open-market purchase and 5 insiders made 15 open-market sales worth $9.9M, as reported on SEC Form 4. All 15 sales were scheduled in advance or made to cover tax on vesting shares, so they say less about the insider's view of the stock. Over the last 12 months, 5 insiders sold $17.4M, of which $17.4M was scheduled or tax-related.

Insider buys, 90 days
0
$0 · 0 insiders
Insider sales, 90 days
15
$9.9M · 5 insiders
Insider buys, 12 months
0
$0 · 0 insiders
Insider sales, 12 months
28
$17.4M · 5 insiders

This is the public summary. Create a free account to see GILD’s AI Signal, the price chart with every insider trade plotted, and each insider’s track record.

Unlock GILD

Recent open-market insider trades

Trades by the same insider within a week are shown as one line.

No discretionary open-market insider trades were reported in the last 12 months.

Scheduled and tax-related sales

Sales made under a pre-arranged 10b5-1 plan or to cover tax on vesting shares. They are listed separately because they are not a fresh decision to sell.

Scheduled and tax-related insider sales at GILEAD SCIENCES, INC.
DateInsiderTypeSharesPriceValue
Daniel Patrick O'Day
CEO
10b5-1 sale
3 trades
15,000avg. $148.64$2.2M
ANTHONY WELTERS
Director
10b5-1 sale
4 trades
18,000avg. $148.62$2.7M
Jeffrey Bluestone
Director
10b5-1 sale
5 trades
5,000avg. $145.02$725K
Johanna Mercier
Chief Comm & Corp Aff Office
10b5-1 sale
2 trades
28,000avg. $137.64$3.9M
Andrew D Dickinson
CFO
10b5-1 sale3,000$138.36$415K
Andrew D Dickinson
CFO
10b5-1 sale3,000$129.93$390K
Johanna Mercier
Chief Comm & Corp Aff Office
10b5-1 sale3,000$129.92$390K
Daniel Patrick O'Day
CEO
10b5-1 sale
2 trades
15,000avg. $126.29$1.9M

What the GILD insider trades really mean

The table above is the public summary. With an Insider Intel account you get the analysis behind it, for GILEAD SCIENCES, INC. and every other stock we track:

The AI Signal weighs:Insider buyingAnalyst ratingPrice upsideAI OutlookInsider track recordBreakout pressure

Plus AI summaries, the latest news for each stock, and an AI assistant you can ask questions about any of it.

Get started free with GILD Insider Intel tracks insider activity at 3,154 companies right now. The Free plan includes full price charts and trade history, watchlists and email alerts.

Questions about GILD insider trading

Who bought GILEAD SCIENCES, INC. (GILD) stock recently?

No insider made an open-market purchase of GILEAD SCIENCES, INC. (GILD) stock in the last 12 months.

Are insiders buying or selling GILD?

Insiders made no discretionary trades in GILD over the last 12 months; the only sales were scheduled or tax-related.

What is a sell-to-cover or 10b5-1 sale?

A 10b5-1 sale is scheduled in advance under a pre-arranged plan, and a sell-to-cover sale is made to pay tax on vesting shares. Neither is a fresh decision to sell, so they say less about an insider's view than a discretionary sale.

Where does this data come from?

Officers, directors and large shareholders report their trades to the SEC on Form 4. This page lists the open-market purchases and sales by individual insiders from those public filings; funds and other institutions are not shown.

Other stocks with recent insider buying

Ready to see GILD in full?

Create a free account and open its chart, score and alerts.

Create your free account

How to read this page

Officers, directors and large shareholders must report their trades in company shares to the SEC on Form 4. This page lists open-market purchases and sales by individual insiders: trades made on the stock exchange at the going price. Funds and other institutions are not shown here.

Information from SEC EDGAR Form 4 filings, shown for general information only. It is not financial advice and does not recommend buying or selling any security. Trades are shown by transaction date and may be reported up to two business days later.